Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors

Neuro-Oncology

Volumn 16, Issue 7, 2014, Pages 975-983

  Desandes, Emmanuel ^a   Guissou, Sandra ^a   Chastagner, Pascal ^a   Lacour, Brigitte ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

children; CNS tumor; incidence; population based study; survival

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; EPENDYMOMA; FEMALE; GLIOBLASTOMA; GLIOMA; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NEWBORN; OVERALL SURVIVAL; PATIENT RISK; PILOCYTIC ASTROCYTOMA; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME; CENTRAL NERVOUS SYSTEM NEOPLASMS; FRANCE; INCIDENCE; KAPLAN MEIER METHOD; PRESCHOOL CHILD; REGISTER;

ADOLESCENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; REGISTRIES;

EID: 84902472509     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not309     Document Type: Article

References (35)

1. Lacour B, Guyot-Goubin A, Guissou S, et al. Incidence of childhood cancer in France: National Children Cancer Registries, 2000-2004. Eur J Cancer Prev. 2010;19:173-181.
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114:97-109.
3. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005;103: 1457-1467.
4. Tycsynski J, Demaret E, Parkin D, eds. Standards and Guidelines for Cancer Registration Network in Europe. The ENCR recommendations. Lyon: IARC Technical Publication n840; 2003.
5. Frizt A, Percy C, Jack A, et al. eds. International Classification of Diseases for Oncology. Third edition. Geneva: World Health Organization; 2000.
6. Parkin D, Kramarova E, Draper GJ, et al. eds. International Incidence of Childhood Cancer Vol.II. IARC Scientific Publications no. 144. Lyon: International Agency for Research on Cancer; 1998.
7. Ries LAG, Smith MA, Gurney JG, et al. eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975- 1995, National Cancer Institute, SEER Program. NIH Pub. No. 99- 4649. Bethesda: National Institutes of Health; 1999.
8. Shuster JJ. Median follow-up in clinical trials. J Clin Oncol. 1991;9: 191-192.
9. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457-481.
10. Mantel N. Evaluation of survival date and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50:163-170.
11. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977;35:1-39.
12. Cox DR, Oakes D, eds. Analysis of Survival Data. New-York: Chapman and Hall; 1990.
13. Bauchet L, Rigau V, Mathieu-Daude H, et al. Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol. 2009;92:87-98.
14. McKinney PA. Central nervous system tumours in children: epidemiology and risk factors. Bioelectromagnetics. 2005;Suppl 7: S60-S68.
15. Schmidt LS, Schmiegelow K, Lahteenmaki P, et al. Incidence of childhood central nervous system tumors in the Nordic countries. Pediatr Blood Cancer. 2011;56:65-69.
16. Central Brain Tumor Registry of the United States-CBTRUS. (2012) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. Available at http://www.cbtrus.org/reports/ reports.html. Accessed August 6, 2012.
17. Brown M, Schrot R, Bauer K, Dodge J. Incidence of first primary central nervous system tumors in California, 2001-2005: children, adolescents and teens. J Neurooncol. 2009;94:263-273.
18. National Cancer Institute-The Surveillance Epidemiology and End Results (SEER) Program. (2012) SEER Cancer Statistics Review 1975-2009. Available at http://seer.cancer.gov/csr/1975-2009- pops09/index.html. Accessed August 6, 2012.
19. Lannering B, Sandstrom PE, Holm S, et al. Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984-2005. Acta Paediatr. 2009;98:1620-1627.
20. Rosychuk RJ, Witol A, Wilson B, Stobart K. Central nervous system (CNS) tumor trends in children in a western Canadian province: a population-based 22-year retrospective study. J Neurol. 2012;259: 1131-1136.
21. Spix C, Eletr D, Blettner M, Kaatsch P. Temporal trends in the incidence rate of childhood cancer in Germany 1987-2004. Int J Cancer. 2008;122:1859-1867.
22. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer. 2008;112:416-432.
23. Australian Paediatric Cancer Registry. (2010) Childhood cancer survival in Australia, 1995- 2004. Available at http://www.cancerqld.org.au/icms-docs/ 60676-Childhood-cancer-survival-in- Australia-1995-2004.pdf. Accessed September 3, 2013.
24. German Childhood Cancer Registry. (2012) Annual Report 2011. Available at http://www.kinderkrebsregister.de/dkkr-gb/veroeffentlichungen/annual-reports. html?L=1. Accessed September 3, 2013.
25. Childhood Cancer Research Group. (2010) Survival from childhood cancer, Great Britain, 1971-2005. Available at http://www.ccrg. ox.ac.uk/datasets/ availabledata.shtml. Accessed September 3, 2013.
26. Villano JL, Propp JM, Porter KR, et al. Malignant pineal germ-cell tumors: an analysis of cases from three tumor registries. Neuro Oncol. 2008;10:121-130.
27. Villano JL, Virk IY, Ramirez V, et al. Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysis. Neuro Oncol. 2010;12:257-264.
28. Qaddoumi I, Sultan I, Gajjar A. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database. Cancer. 2009;115: 5761-5770.
29. Fouladi M, Hunt DL, Pollack IF, et al. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Cancer. 2003;98:1243-1252.
30. Chastagner P, Kalifa C, Doz F, et al. Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot Study. Pediatr Blood Cancer. 2007;49:803-807.
31. Kool M, Koster J, Bunt J, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One. 2008;3:e3088.
32. Desandes E, Berger C, Tron I, et al. Childhood cancer survival in France, 1990-1999. Eur J Cancer. 2008;44:205-215.
33. Koshy M, Rich S, Merchant TE, et al. Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma. J Neurooncol. 2011;105:583-590.
34. Magnani C, Aareleid T, Viscomi S, Pastore G, Berrino F. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study. Eur J Cancer. 2001;37:711-721.
35. von Bueren AO, von Hoff K, Pietsch T, et al. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol. 2011;13:669-679.